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Noninvasive quantification of myocardial perfusion in ab-
solute terms has gained increasing interest recently. Al-
though the technique has been available for 2 decades, only
lately quantification has become feasible in clinical routine.
This has been facilitated by wider clinical use of positron
emission tomography (PET) in cardiac patients and the
technical development of imaging cameras and software.
See page 1807
The detection of functional consequences of epicardial
coronary artery disease (CAD) has an established role in
guiding the therapy of the disease (1). The traditional
assessment of myocardial perfusion has been based on its
relative distribution. This approach has obvious limitations
because the interpretation is based on the assumption that
the best perfused region is normal and can be used as a
reference.
Measuring myocardial perfusion in quantitative terms
is expected to provide benefits in several clinical scenarios
(2,3). In multivessel disease, myocardial perfusion reserve
may be variably abnormal in all territories, thereby
reducing the heterogeneity of perfusion between “nor-
mal” and “abnormal” zones. An extreme case of multi-
vessel disease is diffuse CAD or balanced disease in which
perfusion is abnormally low in all myocardial regions.
Typically, in relative analysis of perfusion, the images look
homogeneous and the disease can be completely missed if
no other signs of multivessel disease are evident. In addition,
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has recently gained more attention. Estimates of myocardial
perfusion contain independent prognostic information
about future major cardiac events and perfusion assessment
is also useful in the monitoring of the effectiveness of risk
reduction strategies (1).
Cardiac computed tomography (CT) enables visualiza-
tion of coronary stenoses, and several studies have demon-
strated a high negative predictive value for CAD (4).
Although contrast-enhanced CT is able to assess coronary
artery lumen, there is often discrepancy between anatomy
and myocardial blood supply. In addition to technical
limitations of CT, the vasomotor tone and coronary collat-
eral flow cannot be estimated because the degree of stenosis
is only a weak descriptor of coronary resistance. In accord
with this, only about half of the anatomically significant
lesions detected with CT coronary angiography are flow
limiting (5). The unique feature of CT angiography is that
it allows characterization of coronary plaque morphology
and composition as well as vessel remodeling, and these
have been believed to provide additional prognostic infor-
mation. However, the clinical value of these findings is not
yet clear.
The paper by Naya et al. (6) in this issue of the Journal
focused on this topic and assessed the link between coronary
atherosclerosis morphology detected by CT angiography
and myocardial perfusion and perfusion reserve as measured
in absolute terms using PET and rubidium-82. The ath-
erosclerosis plaque burden, morphology, and composition
were carefully analyzed in 73 consecutive patients using
current standard CT. Regional and global myocardial per-
fusion was quantified at rest and during pharmacologic
hyperemia.
As expected, the authors found that global quantitative
estimates of myocardial perfusion parameters were sensitive
markers for the identification of patients with high-risk
anatomic disease by CT angiography. Also, in agreement
with earlier findings, they found only a modest relationship
between the degree of stenosis severity by CTA and its
downstream effect on myocardial perfusion parameters such
as hyperemic perfusion, perfusion reserve, and coronary
vascular resistance as assessed per vessel region. Interest-
ingly, total plaque length, composition, and remodeling
index were not associated with perfusion parameters. On
the other hand, on a per-patient basis, the modified Duke
CAD index and the number of segments with mixed plaque
composition were the best predictors of low global perfusion
reserve.
These results suggest that CT angiography–based de-
scriptors of coronary atherosclerosis do not add incremental
information beyond the quantitative percentage of diameter
stenosis for predicting impaired tissue perfusion. However,
this does not necessarily mean that these CTA descriptors
would not provide incremental prognostic value over myo-
cardial perfusion because this study was not designed to
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study with follow-up. However, the extent of atherosclerosis
was associated with decreased tissue perfusion, suggesting a
link between noncalcified plaques as a surrogate marker of
more diffuse coronary microvascular dysfunction.
Interestingly but not surprisingly, Naya et al. (6) detected
quite widespread physiologic variability in perfusion param-
eters, even in coronary territories supplied by angiographi-
cally normal vessels or those with nonobstructive disease.
This is a known phenomenon from numerous studies
linking abnormal perfusion reserve with risk factors for
CAD such as hyperlipidemia, hypertension, and diabetes.
Based on this study, the quantitative assessment of perfusion
would be a very sensitive but not a specific marker for
obstructive epicardial CAD. However, this does not exclude
that low myocardial perfusion may have prognostic value
beyond the diagnosis of CAD.
In our recent study with quantification of myocardial
perfusion, we also found a small number of patients (6%)
who had low absolute stress perfusion without epicardial
CAD (2). However, in that study, the perfusion in nonste-
nosed vessel regions in patients with significant stenoses
elsewhere was not commonly reduced and did not cause
noteworthy problems in assessing the functional severity of
CAD. The difference between the results of the Naya et al.
(6) study and our study may be attributed to differences in
patient populations. In patients with more advanced CAD,
the likelihood of diffuse atherosclerosis and the vascular
damage caused by risk factors is likely higher. The patients
in the study by Naya et al. had apparently more risk factors
and generally more severe atherosclerosis. Different perfu-
sion tracers were used in these studies, and this could
have played some role, although quantification using
rubidium-82 has been also quite well validated.
One of the main limitations of this study, in addition to
a rather small population of patients with significant CAD,
was the lack of a reference standard for both anatomic andfunctional parameters. CT angiography is known to over-
estimate stenoses. Also, CT angiography cannot exclude
that the reduction of perfusion in vessels with nonsignificant
stenoses was not due to coronary artery disease. A larger
cohort with invasive measurements needs to be studied
prospectively to better understand the relationship between
perfusion parameters and coronary atherosclerosis. Also, the
study could not analyze the power of combined data (hybrid
imaging) from CT angiography and perfusion imaging for
the diagnosis of CAD due to lack of a reference standard.
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